Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...
YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced its ...
Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...
The prices of mineral fertilizers are rising. The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is ...
The main market opportunities involve providing training and solutions for regulatory compliance and V&V best practices in regulated industries. This includes developing Master Validation Plans, ...
Froya Organics reports that the anti-aging trend shifts towards organic products, emphasizing long-term skin health over ...
Because many of us fear underwatering our lawns —especially if we don't live in particularly rainy climates—we end up ...
A discussion of the rapid integration of AI in the US insurance industry, the legal and ethical challenges arising from AI ...
Though Biden political appointees and sympathetic civil service government workers defended the last-minute adoption as ...
Long-short equity hedge funds try to beat the market by taking long positions in their favourite firms and going short or ...
By promoting transparency, competition, and institutional accountability, the NIH could reward scientific excellence and ...
Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results